Mirai Sozo Investments
This project aims to establish a startup that develops and commercializes a novel non-invasive therapeutic device utilizing alternating magnetic fields as a physical stimulus for cancer treatment. By positioning it as a "fourth modality" alongside surgery, radiotherapy, and chemotherapy, we seek to improve treatment outcomes and enhance the quality of life (QOL) of patients with refractory cancers, including glioblastoma.
We will provide our customers, medical institutions, with a non-invasive, side-effect-free alternating magnetic field therapy device for glioblastoma, a type of malignant brain tumor.
During this period, our goals are to:
• conduct non-clinical studies,
• establish guidelines for device improvements toward productization, and
• obtain LOIs (Letters of Intent) from potential early-adopter customers,
with the aim of securing investment interest from venture capital firms.